Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability

To improve the specificity and penetration of anticancer peptides against tumors, in this study, we examined the effects of co-administration of the membrane-active peptide HPRP-A1 and the tumor homing/penetrating peptide iRGD. iRGD peptide is widely recognized as an efficient cell membrane penetrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Cuihua, Chen, Xiaolong, Huang, Yibing, Chen, Yuxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797073/
https://www.ncbi.nlm.nih.gov/pubmed/29396568
http://dx.doi.org/10.1038/s41598-018-20715-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797073/
https://www.ncbi.nlm.nih.gov/pubmed/29396568
http://dx.doi.org/10.1038/s41598-018-20715-4

Ejemplares similares